EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent-Reference-Cited by-同舟云学术

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

Published:2024-08 Issue:2 Volume:86 Page:148-163
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Cornford Philip,van den Bergh Roderick C.N.,Briers Erik,Van den Broeck Thomas,Brunckhorst Oliver,Darraugh Julie,Eberli Daniel,De Meerleer Gert,De Santis Maria,Farolfi Andrea,Gandaglia Giorgio,Gillessen Silke,Grivas Nikolaos,Henry Ann M.,Lardas Michael,van Leenders Geert J.L.H.,Liew Matthew,Linares Espinos Estefania,Oldenburg Jan,van Oort Inge M.,Oprea-Lager Daniela E.,Ploussard Guillaume,Roberts Matthew J.,Rouvière Olivier,Schoots Ivo G.,Schouten Natasha^ORCID,Smith Emma J.,Stranne Johan,Wiegel Thomas,Willemse Peter-Paul M.,Tilki Derya

Publisher

Elsevier BV

Reference141 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis and local treatment with curative intent;Mottet;Eur Urol,2021

2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer;Cornford,2024

3. Going from evidence to recommendations;Guyatt;BMJ,2008

4. Recent global patterns in prostate cancer incidence and mortality rates;Culp;Eur Urol,2020

5. Prostate cancer risk prediction based on complete prostate cancer family history;Albright;Prostate,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study;European Urology Open Science;2024-10

2. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

3. MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer;European Radiology;2024-09-13

4. The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-12

5. MRI accuracy for recurrence after partial gland ablation with HIFU for localized prostate cancer. A systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-10